Short TDP-43 Isoforms as Therapeutic Targets and Biomarkers for Amyotrophic Lateral Sclerosis
Abstract
Here we present the annual progress report of the project entitled 'Short TDP-43 Isoforms as Therapeutic Targets and Biomarkers for Amyotrophic Lateral Sclerosis'. The goal of this report is to show progress toward specific aims, achievements, stage of completion, as well as obtained HRPO, ORP forms, and IRB protocol approval. The report includes preliminary results, difficulties, and mitigation actions to ensure work continuation.
Document Details
- Document Type
- Technical Report
- Publication Date
- May 01, 2022
- Accession Number
- AD1168866
Entities
People
- Paul Valdmanis
- Sami Barmada
- Veronique Belzil
Organizations
- Mayo Clinic